-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Maintains Neutral on Doximity, Lowers Price Target to $28

Benzinga·04/09/2026 17:42:30
Listen to the news
Goldman Sachs analyst David Roman maintains Doximity (NYSE:DOCS) with a Neutral and lowers the price target from $34 to $28.